We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Dr Nathan Moore

Dr Nathan Moore

Associate Director, Engineering & Automation Cell Therapies, Pharmaceutical Sciences Takeda

Contact Us


Latest Content
Applying a Closed, Modular, Semi-Automated System to CAR T Cell Therapy Manufacturing content piece image
Webinar

Applying a Closed, Modular, Semi-Automated System to CAR T Cell Therapy Manufacturing

Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the market.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter